Pooled Analysis Comparing the Efficacy of Intracoronary Versus Intravenous Abciximab in Smokers Versus Nonsmokers Undergoing Primary Percutaneous Coronary Revascularization for Acute ST-Elevation Myocardial Infarction-Reference-Cited by-同舟云学术

Pooled Analysis Comparing the Efficacy of Intracoronary Versus Intravenous Abciximab in Smokers Versus Nonsmokers Undergoing Primary Percutaneous Coronary Revascularization for Acute ST-Elevation Myocardial Infarction

Published:2016-12 Issue:12 Volume:118 Page:1798-1804
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Piccolo Raffaele,Galasso Gennaro,Eitel Ingo,Dominguez-Rodriguez Alberto,Iversen Allan Zeeberg,Gu Youlan L.,Abreu-Gonzalez Pedro,de Smet Bart J.G.L.,Esposito Giovanni,Windecker Stephan,Thiele Holger,Piscione Federico

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference30 articles.

1. The “smoker's paradox” in patients with acute coronary syndrome: a systematic review;Aune;BMC Med,2011

2. Unravelling the smokers' paradox: cigarette smoking, high-risk coronary artery disease and enhanced clinical efficacy of oral P2Y(1)(2) inhibitors;Gurbel;Thromb Haemost,2014

3. Evaluation of paradoxic beneficial effects of smoking in patients receiving thrombolytic therapy for acute myocardial infarction: Mechanism of the “smoker's paradox” from the GUSTO-I trial, with angiographic insights

4. Impact of smoking status on outcomes of primary coronary intervention for acute myocardial infarction–the smoker's paradox revisited;Weisz;Am Heart J,2005

5. Impact of smoking on outcomes of patients with ST-segment elevation myocardial infarction (from the HORIZONS-AMI Trial);Goto;Am J Cardiol,2011

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Meta-Analysis Comparing Outcomes of Smokers Versus Nonsmokers With Acute Coronary Syndrome Underwent Percutaneous Coronary Intervention;The American Journal of Cardiology;2018-09

2. Meta-Analysis of Randomized Trials of Intracoronary Versus Intravenous Glycoprotein IIb/IIIa Inhibitors in Patients With ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention;The American Journal of Cardiology;2017-10